Takeda Pharmaceutical Company Limited is a global, research-driven biopharmaceutical company based in Japan. Founded in 1781, the company discovers, develops, manufactures, and markets prescription medicines and vaccines. Its core therapeutic areas include gastroenterology and inflammation, oncology, neuroscience, rare genetic and hematology diseases, plasma-derived therapies, and vaccines.
Takeda operates an international R&D and manufacturing network that spans small‑molecule and biologic modalities. Capabilities include medicinal chemistry, process and scale-up chemistry, biologics development and production, plasma fractionation, and formulation and fill‑finish. The company produces active pharmaceutical ingredients (APIs) and finished dosage forms for global markets, supplying healthcare systems in numerous countries. Its activities intersect with the broader chemical value chain through API synthesis, process development, quality control, and compliance with global cGMP and regulatory standards.
